Ani Pharmaceuticals: Pay

Ani Pharmaceuticals paid its 5 named executives $21.6M in total in FY2025 (Dec). CEO Nikhil Lalwani was paid $10.3M of that.

Pay$100 in the stock at the end of FY20 → $272
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Nikhil LalwaniPresident and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Christopher K. MutzSenior Vice President, Head of Rare Disease
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Stephen P. CareySenior Vice President, Finance and Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Meredith W. CookSenior Vice President, General Counsel and Corporate Secretary
FY2025 (Dec)
FY2024 (Dec)
2 years
Ori GutwergSenior Vice President, Generics
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 8 peers with pay on file was $12.9M. CEO pay of Ani Pharmaceuticals for that year is not on file.

  1. 1TG Therapeutics
  2. 2PTC Therapeutics
  3. 3Supernus Pharmaceuticals
  4. 4INSMED
  5. 5Ultragenyx Pharmaceutical
  6. 6Travere Therapeutics
  7. 7Aurinia Pharmaceuticals
  8. 8Collegium Pharmaceutical
  9. 9Ani PharmaceuticalsNot disclosed
  10. 10Acadia PharmaceuticalsNot disclosed
  11. 11Amicus Therapeutics, Inc.Not disclosed
  12. 12Amphastar Pharmaceuticals, Inc.Not disclosed
  13. 13Biocryst PharmaceuticalsNot disclosed
  14. 14Catalyst Pharmaceuticals, Inc.Not disclosed
  15. 15Corcept TherapeuticsNot disclosed
  16. 16Ironwood Pharmaceuticals, Inc.Not disclosed
  17. 17Myriad Genetics, Inc.Not disclosed
  18. 18Pacira BioSciencesNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.